Abstract:Targeted axillary dissection (TAD) is an axillary staging technique after NACT that involves the removal of biopsy-proven metastatic lymph nodes in addition to sentinel lymph node biopsy (SLNB). This technique avoids the morbidity of traditional axillary lymph node dissection and has shown a lower false-negative rate than SLNB alone. Therefore, marking positive axillary lymph nodes before NACT is critical in order to locate and remove them in the subsequent surgery. Current localization methods include clip pl… Show more
“…The role of MRI is also being highlighted, as although it has a lower spatial resolution, it provides an overview of the 'T', and of contralateral lymph node status. In another review work, Di Paola et al [8] gave an overview of image-guide techniques for localizing metastatic lymph nodes at diagnosis in patients who will be treated with NST. In the NST setting marking positive lymph nodes (LNs) at the time of diagnosis allows for their removal during post-NST surgery because the LNs at diagnosis do not always coincide with SLNs after NST.…”
“…The role of MRI is also being highlighted, as although it has a lower spatial resolution, it provides an overview of the 'T', and of contralateral lymph node status. In another review work, Di Paola et al [8] gave an overview of image-guide techniques for localizing metastatic lymph nodes at diagnosis in patients who will be treated with NST. In the NST setting marking positive lymph nodes (LNs) at the time of diagnosis allows for their removal during post-NST surgery because the LNs at diagnosis do not always coincide with SLNs after NST.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.